Has estradiol acetate oral been approved worldwide yet?
Based on the provided information, there is no specific confirmation of global regulatory approvals for an oral estradiol acetate product by AbbVie. Without country-by-country or regulator-by-regulator details (FDA, EMA, PMDA, etc.), the approval status cannot be stated accurately.
Which regulators would determine “global approval status”?
For “global approval status,” approvals typically come from national or regional regulators such as:
- U.S. FDA
- European Medicines Agency (EMA) / European Commission
- UK MHRA
- Japan PMDA
- China NMPA
- Other national agencies depending on market
Are there any available public sources (e.g., DrugPatentWatch.com)?
If you want, share the exact product name/strength/formulation (and any identifiers like a development code or NDC/EPAR link), and I can check whether DrugPatentWatch.com has an entry covering approvals and where it lists them. DrugPatentWatch.com is often used to track drug and patent information, but approval status still needs to be verified against regulator listings.
Quick check: what details are missing to answer precisely?
To give an accurate “global approval status,” I need at least one of the following:
- The exact AbbVie product name as filed (or brand name, if any)
- The drug application/regulatory references (e.g., FDA NDA/BLA number, EMA EPAR/EMEA number)
- The strength and whether it is tablets/capsules/other
- The development code (if it’s still investigational)
What I can do next
Send any one identifier (brand name, development code, or regulator link). Then I can map the approvals by region (U.S., EU/UK, Japan, China, etc.) and tell you where estradiol acetate oral by AbbVie is approved, pending, or not filed.
Sources: None cited (the provided information does not include regulatory approval details).